Form4insider filings, from the source

Company · CIK 0001478320 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Adaptive Biotechnologies Corp · ADPT

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $53.8M · 21net −$53.8M
$10k$10k$1M$1M$100M$100MbuyssalesJun 3Jun 20Jul 8Jul 26Aug 12Aug 30Sep 17

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 SForm 4 →Sep 18, 8:17 pm EDTFrancis LoChief People Officer115,406$28.06$3,238,004220,867−34.3%10b5-1
Sep 16, 2026 MForm 4 →Sep 18, 8:17 pm EDTFrancis LoChief People Officer105,560$9.57$1,010,581336,273—10b5-1
Sep 15, 2026 SForm 4 →Sep 17, 6:50 pm EDTSusan BobulskyChief Commercial Officer, MRD1,195$27.00$32,265395,794−0.30%10b5-1
Aug 31, 2026 GForm 4 →Sep 2, 7:12 pm EDTKatey Einterz OwenDirector12,539——66,100—
Aug 26, 2026 SForm 4 →Aug 28, 5:50 pm EDTKatey Einterz OwenDirector9,615$26.00$249,99078,639−10.9%
Aug 18, 2026 SForm 4 →Aug 20, 5:55 pm EDTRobert HershbergDirector30,664$24.40$748,20846,683−39.6%
Aug 18, 2026 MForm 4 →Aug 20, 5:55 pm EDTRobert HershbergDirector15,000$6.32$94,80077,347—
Aug 17, 2026 SForm 4 →Aug 19, 8:15 pm EDTChad M RobinsCEO and Chairman, Director600,000$24.80$14,882,1662,180,518−21.6%
Aug 17, 2026 MForm 4 →Aug 19, 8:15 pm EDTChad M RobinsCEO and Chairman, Director600,000$6.55$3,930,0002,459,194—
Aug 17, 2026 SForm 4 →Aug 19, 8:07 pm EDTPeter M NeupertDirector124,690$25.15$3,135,850130,625−48.8%
Aug 17, 2026 MForm 4 →Aug 19, 8:07 pm EDTPeter M NeupertDirector15,000$6.32$94,800255,315—
Aug 10, 2026 SForm 4 →Aug 12, 7:33 pm EDTSusan BobulskyChief Commercial Officer, MRD3,000$25.00$75,000396,989−0.75%10b5-1
Jul 30, 2026 SForm 4 →Aug 3, 6:26 pm EDTSusan BobulskyChief Commercial Officer, MRD1,299$24.00$31,176399,989−0.32%10b5-1
Jul 21, 2026 SForm 4 →Jul 23, 7:34 pm EDTHarlan S RobinsChief Scientific Officer492,400$21.89$10,780,409812,058−37.7%10b5-1
Jul 21, 2026 MForm 4 →Jul 23, 7:34 pm EDTHarlan S RobinsChief Scientific Officer284,800$6.55$1,865,4401,304,458—10b5-1
Jul 16, 2026 SForm 4 →Jul 20, 7:19 pm EDTSusan BobulskyChief Commercial Officer, MRD5,000$23.00$115,000401,288−1.23%10b5-1
Jul 15, 2026 SForm 4 →Jul 17, 7:23 pm EDTFrancis LoChief People Officer105,762$22.59$2,389,164230,713−31.4%10b5-1
Jul 15, 2026 MForm 4 →Jul 17, 7:23 pm EDTFrancis LoChief People Officer105,762$8.91$942,691336,475—10b5-1
Jul 2, 2026 SForm 4 →Jul 7, 6:52 pm EDTHarlan S RobinsChief Scientific Officer386,240$22.01$8,501,1491,019,658−27.5%10b5-1
Jul 1, 2026 SForm 4 →Jul 6, 7:19 pm EDTFrancis LoChief People Officer95,842$22.51$2,157,683230,713−29.3%10b5-1
Jul 1, 2026 MForm 4 →Jul 6, 7:19 pm EDTFrancis LoChief People Officer75,621$8.75$661,885275,551—10b5-1
Jul 1, 2026 SForm 4 →Jul 6, 7:15 pm EDTSusan BobulskyChief Commercial Officer, MRD487$22.00$10,714406,288−0.12%10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 7:25 pm EDTSharon BenzenoChief Commercial Ofc Imm Med165,802$21.13$3,503,510221,278−42.8%10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 7:25 pm EDTSharon BenzenoChief Commercial Ofc Imm Med114,329$7.75$885,555376,046—10b5-1
Jun 25, 2026 SForm 4 →Jun 29, 7:52 pm EDTSusan BobulskyChief Commercial Officer, MRD5,000$20.50$102,500406,775−1.21%10b5-1
Jun 25, 2026 SForm 4 →Jun 29, 7:49 pm EDTMichelle Renee GriffinDirector52,084$20.18$1,051,05515,625−76.9%10b5-1
Jun 25, 2026 MForm 4 →Jun 29, 7:49 pm EDTMichelle Renee GriffinDirector52,084$7.80$406,25567,709—10b5-1
Jun 15, 2026 SForm 4 →Jun 17, 8:11 pm EDTHarlan S RobinsChief Scientific Officer106,160$17.41$1,847,9421,405,898−7.02%10b5-1
Jun 11, 2026 SForm 4 →Jun 15, 7:13 pm EDTSusan BobulskyChief Commercial Officer, MRD5,000$19.00$95,000411,775−1.20%10b5-1
Jun 4, 2026 SForm 4 →Jun 8, 8:29 pm EDTFrancis LoChief People Officer39,741$17.49$695,070250,934−13.7%10b5-1
Jun 4, 2026 MForm 4 →Jun 8, 8:29 pm EDTFrancis LoChief People Officer19,521$8.85$172,797290,675—10b5-1
Jun 4, 2026 SForm 4 →Jun 8, 8:27 pm EDTSusan BobulskyChief Commercial Officer, MRD11,000$18.00$198,000416,775−2.57%10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 MForm 4 →Sep 18, 8:17 pm EDTFrancis LoChief People Officer105,560——103,142—10b5-1
Aug 18, 2026 MForm 4 →Aug 20, 5:55 pm EDTRobert HershbergDirector15,000——0—
Aug 17, 2026 MForm 4 →Aug 19, 8:15 pm EDTChad M RobinsCEO and Chairman, Director600,000——0—
Aug 17, 2026 MForm 4 →Aug 19, 8:07 pm EDTPeter M NeupertDirector15,000——0—
Jul 21, 2026 MForm 4 →Jul 23, 7:34 pm EDTHarlan S RobinsChief Scientific Officer284,800——0—10b5-1
Jul 15, 2026 MForm 4 →Jul 17, 7:23 pm EDTFrancis LoChief People Officer105,762——37,511—10b5-1
Jul 1, 2026 MForm 4 →Jul 6, 7:19 pm EDTFrancis LoChief People Officer75,621——60,222—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 7:25 pm EDTSharon BenzenoChief Commercial Ofc Imm Med114,329——113,457—10b5-1
Jun 25, 2026 MForm 4 →Jun 29, 7:49 pm EDTMichelle Renee GriffinDirector52,084——0—10b5-1
Jun 4, 2026 MForm 4 →Jun 8, 8:29 pm EDTFrancis LoChief People Officer19,521——140,648—10b5-1